BioBright, an 11-person startup based in Boston that automates data flow from laboratory instruments to a secure cloud, has been acquired by Herts, U.K.-based Dotmatics. No financial terms were disclosed.
Founded in 2015 and initially funded by the Defense Advanced Research Projects Agency (DARPA), BioBright's aim is to create "the smart laboratory of the future." The startup has worked with a variety of pharmaceutical and biotech companies, including Merck and Sanofi, BioBright VP of engineering Hisham Barradah told BostInno in an interview in April.
"We're machine-agnostic," Barradah said. "We get [data] all into a central place where [researchers] can then run analysis on them."
BioBright's projects are designed to enable scientists to automate the collection of data from in-house and externally networked sources, then standardize and analyze crucial experimental data with validation and integrity checks built in. Along with other initiatives, the startup monitors network traffic on laboratory equipment and uses machine learning to understand and make that traffic more efficient.
Last June, BioBright partnered with Philips to develop informatic solutions designed to enable clinicians to quickly input and access patient information. That partnership followed BioBright's previous participation in the Philips HealthWorks Startup Program in Cambridge.
With the acquisition, the full portfolio of BioBright's solutions will be available through Dotmatics. Founded in 2005, Dotmatics has a similar mission to BioBright's: It aims to drive the automation of laboratory data workflows for scientific discovery and innovation research.
"For the first time, world-leading informatics and lab data automation platforms are being brought together under a single vendor," Dotmatics co-founder and CEO Stephen Gallagher said in a statement. "We are delighted to welcome our new BioBright colleagues to Dotmatics and look forward to working together to create a game-changing solution for our customers’ journey towards the Lab of the Future."
